4.7 Article

Loss of p53 results in protracted electrographic seizures and development of an aggravated epileptic phenotype following status epilepticus

期刊

CELL DEATH & DISEASE
卷 1, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/cddis.2010.55

关键词

apoptosis; Bcl-2; epileptogenesis; hippocampal sclerosis; kainate; video-EEG

资金

  1. Health Research Board Ireland [RP/2005/24, RP/2007/37]
  2. Science Foundation Ireland [04/IN3/B466, 08/IN1/B1875, 08/RFP/NSC1745]
  3. Irish Research Council for Science Engineering and Technology
  4. Health Research Board
  5. Science Foundation Ireland (SFI) [08/RFP/NSC1745] Funding Source: Science Foundation Ireland (SFI)

向作者/读者索取更多资源

The p53 tumor suppressor is a multifunctional protein, which regulates cell cycle, differentiation, DNA repair and apoptosis. Experimental seizures up-regulate p53 in the brain, and acute seizure-induced neuronal death can be reduced by genetic deletion or pharmacologic inhibition of p53. However, few long-term functional consequences of p53 deficiency have been explored. Here, we investigated the development of epilepsy triggered by status epilepticus in wild-type and p53-deficient mice. Analysis of electroencephalogram (EEG) recordings during status epilepticus induced by intra-amygdala kainic acid (KA) showed that seizures lasted significantly longer in p53-deficient mice compared with wild-type animals. Nevertheless, neuronal death in the hippocampal CA3 subfield and the neocortex was significantly reduced at 72 h in p53-deficient mice. Long-term continuous EEG telemetry recordings after status epilepticus determined that the sum duration of spontaneous seizures was significantly longer in p53-deficient compared with wild-type mice. Hippocampal damage and neuropeptide Y distribution at the end of chronic recordings was found to be similar between p53-deficient and wild-type mice. The present study identifies protracted KA-induced electrographic status as a novel outcome of p53 deficiency and shows that the absence of p53 leads to an exacerbated epileptic phenotype. Accordingly, targeting p53 to protect against status epilepticus or related neurologic insults may be offset by deleterious consequences of reduced p53 function during epileptogenesis or in chronic epilepsy. Cell Death and Disease (2010) 1, e79; doi: 10.1038/cddis.2010.55; published online 7 October 2010

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Gastroenterology & Hepatology

Patients with mesenchymal tumours and high Fusobacteriales prevalence have worse prognosis in colorectal cancer (CRC)

Manuela Salvucci, Nyree Crawford, Katie Stott, Susan Bullman, Daniel B. Longley, Jochen H. M. Prehn

Summary: The study identifies CMS4/CRIS-B patients with high Fn/Fusobacteriales prevalence as a high-risk subpopulation that may benefit from therapeutics targeting mesenchymal biology.
Article Biochemical Research Methods

FLINO: a new method for immunofluorescence bioimage normalization

John Graf, Sanghee Cho, Elizabeth McDonough, Alex Corwin, Anup Sood, Andreas Lindner, Manuela Salvucci, Xanthi Stachtea, Sandra Van Schaeybroeck, Philip D. Dunne, Pierre Laurent-Puig, Daniel Longley, Jochen H. M. Prehn, Fiona Ginty

Summary: The study presented a new immunoFLuorescence Image NOrmalization method and evaluated it against alternative methods using multiround immunofluorescence staining with DAPI. Comparison of multiple normalization methods showed that upper quartile normalization of grid objects in log space had nearly equivalent performance to normalizing segmented cell objects by the middle quantile.

BIOINFORMATICS (2022)

Article Biochemistry & Molecular Biology

An atlas of inter- and intra-tumor heterogeneity of apoptosis competency in colorectal cancer tissue at single-cell resolution

Andreas Ulrich Lindner, Manuela Salvucci, Elizabeth McDonough, Sanghee Cho, Xanthi Stachtea, Emer P. O'Connell, Alex D. Corwin, Alberto Santamaria-Pang, Steven Carberry, Michael Fichtner, Sandra Van Schaeybroeck, Pierre Laurent-Puig, John P. Burke, Deborah A. McNamara, Mark Lawler, Anup Sood, John F. Graf, Markus Rehm, Philip D. Dunne, Daniel B. Longley, Fiona Ginty, Jochen H. M. Prehn

Summary: The study utilized multiplexed immunofluorescence analysis to quantify 18 cell lineage and apoptosis proteins in different cells, revealing differences in apoptosis sensitivity. Single-cell resolution systems modeling identified enhanced sensitivity of cancer cells to mitochondrial permeabilization and executioner caspase activation compared to immune and stromal cells, with significant inter- and intra-tumor heterogeneity.

CELL DEATH AND DIFFERENTIATION (2022)

Article Pathology

Stratification of chemotherapy-treated stage III colorectal cancer patients using multiplexed imaging and single-cell analysis of T-cell populations

Xanthi Stachtea, Maurice B. Loughrey, Manuela Salvucci, Andreas U. Lindner, Sanghee Cho, Elizabeth McDonough, Anup Sood, John Graf, Alberto Santamaria-Pang, Alex Corwin, Pierre Laurent-Puig, Sonali Dasgupta, Jinru Shia, Jonathan R. Owens, Samantha Abate, Sandra Van Schaeybroeck, Mark Lawler, Jochen H. M. Prehn, Fiona Ginty, Daniel B. Longley

Summary: In this study, immune signatures in the tumor and tumor microenvironment were assessed using a multiplexed immunofluorescence imaging technology, revealing a significant association between regulatory T cells (Tregs) and survival rates in colorectal cancer patients. Multi-marker classification provided more accurate quantitation of immune cell types with stronger correlations with patient outcomes compared to single markers.

MODERN PATHOLOGY (2022)

Article Oncology

Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists

Vera Grinkevitch, Mark Wappett, Nyree Crawford, Stacey Price, Andrea Lees, Christopher McCann, Katherine McAllister, Jochen Prehn, Jamie Young, Jess Bateson, Lewis Gallagher, Magali Michaut, Vivek Iyer, Aikaterini Chatzipli, Syd Barthorpe, Daniel Ciznadija, Ido Sloma, Amy Wesa, David A. Tice, Lodewyk Wessels, Mathew Garnett, Daniel B. Longley, Ultan McDermott, Simon S. McDade

Summary: Second-generation TRAIL-R2 agonists face two major clinical challenges: lack of predictive biomarkers and development of resistance. This study identifies caspase-8:FLIP(L) and caspase-8:MCL-1 ratios as potential predictive biomarkers for second-generation TRAIL-R2 agonists, and loss of key effectors like FADD and caspase-8 as likely drivers of clinical resistance in solid tumors.

MOLECULAR CANCER THERAPEUTICS (2022)

Review Cell Biology

Mechanisms and mathematical modeling of ROS production by the mitochondrial electron transport chain

Sandeep Chenna, Werner J. H. Koopman, Jochen H. M. Prehn, Niamh M. C. Connolly

Summary: This article discusses the mechanistic models and minimal models of mitochondrial reactive oxygen species (ROS) homeostasis. Mechanistic models provide valuable insights but are complex, while minimal models use a smaller set of equations to describe empirical relationships and generate hypotheses. Finally, the article illustrates the application of minimal models in studying the pathophysiology of ROS.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2022)

Review Cell Biology

Serine-Arginine Protein Kinase 1 (SRPK1): a systematic review of its multimodal role in oncogenesis

William P. Duggan, Emer O'Connell, Jochen H. M. Prehn, John P. Burke

Summary: Alternative splicing, regulated by SRPK1, is implicated in cancer progression and poor survival. Increased SRPK1 expression is associated with proliferation, invasion, migration, and apoptosis in vitro, as well as tumor growth, tumorigenicity, and metastasis in vivo. Aberrant SRPK1 expression is involved in multiple signaling pathways associated with oncogenesis. SRPK1-targeting microRNAs play a role in regulating SRPK1 activity. SRPK1 expression is closely related to the response of tumors to platinum-based chemotherapy.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2022)

Article Oncology

Bcl-xL Is a Key Mediator of Apoptosis Following KRASG12C Inhibition in KRASG12C-mutant Colorectal Cancer

Hajrah Khawaja, Rebecca Briggs, Cheryl H. Latimer, Mustasin Rassel, Dary Griffin, Lyndsey Hanson, Alberto Bardelli, Frederica Di Nicolantonio, Simon S. McDade, Christopher J. Scott, Shauna Lambe, Manisha Maurya, Andreas U. Lindner, Jochen H. M. Prehn, Jose Sousa, Chris Winnington, Melissa J. LaBonte, Sarah Ross, Sandra Van Schaeybroeck

Summary: Novel covalent inhibitors of KRASG12C have shown limited response rates in patients with KRASG12C-mutant colorectal cancer. In this study, researchers found that the combination of AZ'1569 and a Bcl-xL inhibitor led to a dramatic and universal apoptosis, suggesting a potential therapeutic strategy for patients with KRAS G12C-mutant colorectal cancer.

MOLECULAR CANCER THERAPEUTICS (2023)

Article Cell Biology

Modeling native and seeded Synuclein aggregation and related cellular dysfunctions in dopaminergic neurons derived by a new set of isogenic iPSC lines with SNCA multiplications

Angelo Iannielli, Mirko Luoni, Serena Gea Giannelli, Rosangela Ferese, Gabriele Ordazzo, Matteo Fossati, Andrea Raimondi, Felipe Opazo, Olga Corti, Jochen H. M. Prehn, Stefano Gambardella, Ronald Melki, Vania Broccoli

Summary: In this study, researchers generated a panel of isogenic iPSCs with SNCA gene triplication using gene editing technology. Through this cellular model, they found that loss of growth factor may contribute to mitochondrial dysfunction, increased levels of oxidized dopamine, and alpha-Synuclein aggregation in early DA neurons. Additionally, they observed that exposing neurons to structurally well-characterized synthetic alpha-Synuclein fibrils can accelerate the aggregation process and form deposits resembling Lewy bodies commonly observed in PD patient brain tissues.

CELL DEATH & DISEASE (2022)

Article Cell Biology

Effect of TP53 deficiency and KRAS signaling on the bioenergetics of colon cancer cells in response to different substrates: A single cell study

James Kealey, Heiko Dussmann, Irene Llorente-Folch, Natalia Niewidok, Manuela Salvucci, Jochen H. M. Prehn, Beatrice D'Orsi

Summary: The study reveals that activating KRAS mutations and loss of TP53 remodel cancer metabolism and lead to alterations in bioenergetics under metabolic stress conditions by modulating cellular ATP production, NADH oxidation, mitochondrial respiration and function.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Editorial Material Cell Biology

Purinergic Signalling and Inflammation-Related Diseases

Tobias Engel, Eva Maria Jimenez-Mateos, Miguel Diaz-Hernandez

Article Biochemistry & Molecular Biology

Quantification of substoichiometric modification reveals global tsRNA hypomodification, preferences for angiogenin-mediated tRNA cleavage, and idiosyncratic epitranscriptomes of human neuronal cell-lines

Florian Pichot, Marion C. Hogg, Virginie Marchand, Valerie Bourguignon, Elisabeth Jirstrom, Cliona Farrell, Hesham A. Gibriel, Jochen H. M. Prehn, Yuri Motorin, Mark Helm

Summary: Modification of tRNA is crucial for generating RNA expression diversity. In this study, the stoichiometry of incompletely modified sites in human tRNAs was investigated, and it was found that up to 75% of sites can be incompletely modified. The modification patterns of tRNA populations can provide information to differentiate different cell lines.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2023)

Review Biochemistry & Molecular Biology

The P2X7 Receptor as a Mechanistic Biomarker for Epilepsy

Tobias Engel

Summary: Epilepsy is a brain disease affecting over 70 million people worldwide, characterized by recurrent spontaneous seizures. Challenges in epilepsy management include diagnosis and treatment. Current research aims to identify new drugs with different mechanisms of action for patients not responding to current medications. The P2X7 receptor (P2X7R) has attracted attention as a potential therapeutic and diagnostic target due to its involvement in epilepsy and altered expression in experimental models and patients. This review discusses the latest findings and the potential of P2X7R-based treatments for epilepsy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Endocrinology & Metabolism

tRNA -derived fragments are altered in diabetes

N. Ng, H. A. Y. Gibriel, L. Halang, E. Jirstrom, J. A. Ioana, M. Burke, M. M. Byrne, J. H. M. Prehn

Summary: This study investigated the levels of tiRNA 5'ValCAC (alone and in combination with miR-23b-3p) in serum samples from healthy controls, type 1 diabetes, type 2 diabetes, and MIDD subjects. The results showed reduced levels of 5'ValCAC in MIDD and type 2 diabetes subjects compared to controls, and higher levels of miR-23b-3p in type 2 diabetes subjects. Receiver Operating Characteristic analysis demonstrated the potential of 5'ValCAC and miR-23b-3p as MIDD biomarkers, with the combination showing excellent separation from type 2 diabetes subjects.

DIABETIC MEDICINE (2023)

Meeting Abstract Oncology

Bcl-xL and association with apoptosis following KRASG12C inhibition in KRASG12C mutant colorectal cancer.

Hajrah Khawaja, Rebecca Briggs, Cheryl Latimer, Md A. M. B. Rassel, Daryl Griffin, Lyndsey Hanson, Alberto Bardelli, Federica Di Nicolantonio, Simon McDade, Christopher Scott, Shauna Lambe, Manisha Maurya, Andreas Ulrich Lindner, Jochen H. M. Prehn, Jose Sousa, Chris Winnington, Melissa J. LaBonte, Sarah Ross, Sandra Van Schaeybroeck

JOURNAL OF CLINICAL ONCOLOGY (2022)

暂无数据